LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Nov 10, 2023
Discovery & Translation
Shinobi’s immune-protected cell therapies; plus Emugen, AZ and more
BioCentury’s roundup of translational innovations
Read More
BioCentury
|
Nov 3, 2023
Discovery & Translation
Dimeric IgA targets intracellular oncogenes; plus taRNAs and more
BioCentury’s roundup of translational innovations
Read More
BioCentury
|
Dec 21, 2018
Product Development
China’s clinical talent gap
How Chinese companies are finding the clinical experts they need to run local trials
Read More
BioCentury
|
Jul 14, 2017
Strategy
Transforming BeiGene
Why BeiGene changed its mind about selling its own drugs in China
Read More
BioCentury
|
Jul 7, 2017
Company News
BeiGene grants Celgene PD-1 rights, acquires China operations
Read More
BioCentury
|
Jul 7, 2017
Company News
BeiGene grants Celgene PD-1 rights, acquires China operations
Read More
BioCentury
|
Jan 25, 2017
Distillery Therapeutics
Autoimmune disease
Read More
BioCentury
|
Nov 9, 2016
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Feb 16, 2015
Company News
Trillium Diagnostics, Vivione deal
Read More
BioCentury
|
Jan 22, 2015
Translation in Brief
Boehringer double-dips into academia
Two academic deals for Boehringer Ingelheim
Read More
Items per page:
10
1 - 10 of 21